Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu! Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108 References: https://psychiatryonline.org/doi/10.1176/appi.focus.18103 https://psycnet.apa.org/record/2015-37696-000
Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety. References: https://pubmed.ncbi.nlm.nih.gov/9616188/ https://pubmed.ncbi.nlm.nih.gov/27998379/ https://pubmed.ncbi.nlm.nih.gov/21154375/ https://pubmed.ncbi.nlm.nih.gov/1345410/
We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more! References - https://pubmed.ncbi.nlm.nih.gov/38273108/ - https://pubmed.ncbi.nlm.nih.gov/34113269/ - https://pubmed.ncbi.nlm.nih.gov/39296512/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC12089804/ - https://pubmed.ncbi.nlm.nih.gov/40043464/ - https://pubmed.ncbi.nlm.nih.gov/2...
Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC2899886/ https://www.nature.com/articles/s41398-018-0118-6 https://www.nature.com/articles/s41598-022-15489-9 https://pmc.ncbi.nlm.nih.gov/articles/PMC5913255/...
On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails. Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract ’ One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1 SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720...
On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network. References: https://pubmed.ncbi.nlm.nih.gov/30250390/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4162869/ https://link.springer.com/article/10.3758/s13415-011-0083-5 https://www.cell.com/neuron/comments/S0896-6273(06)00349-7 https://pubmed.ncbi.nlm.nih.gov/18799601/ https://www.nature.com/articles/s41386-021-01132-0...
On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies. ELEKTD: https://www.nejm.org/doi/full/10.1056/NEJMoa2302399 KET-ECT: https://pubmed.ncbi.nlm.nih.gov/35020871/ Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/...
Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network. References https://pmc.ncbi.nlm.nih.gov/articles/PMC7959111/ https://pubmed.ncbi.nlm.nih.gov/37167968/ https://www.nature.com/articles/s42003-019-0611-3 https://www.psychiatrictimes.com/view/mindwandering-mood-for-thought https://www.nature.com/articles/s41380-021-01403-8 https://www.sciencedirect.com/science/article/abs/pii/S0167876022000071 https://www.nature.co...
Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).
On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis. https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/ https://pubmed.ncbi.nlm.nih.gov/34108247/ https://pubmed.ncbi.nlm.nih.gov/25577164/
In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry ( learn more ). https://x.com/jd_rosenblat?lang=en https://pubmed.ncbi.nlm.nih.gov/35688035/ https://pubmed.ncbi.nlm.nih.gov/39608193/
Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.
Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.
Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.
Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.
Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.
Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice.
Welcome back! Today, we have a special guest-episode with a senior medical student, Jun-Hwan Kim. Join us as we talk about anti-psychotic associated weight gain.
Today, we have a very special guest joining us—Dr. John Kane! We will be discussing his experience and history with clozapine, a groundbreaking medication for treatment-resistant schizophrenia.
Join us and we discuss a newer anti-psychotic medication, Lumateperone, brand name Caplyta.
Welcome back to our final partial agonist episode! Today we are discussing Cariprazine, brand name, Vraylar.
Welcome back! Brexpiprazole, also known by its brand name Rexulti, is a relatively new medication. Join us for a brief discussion.
Welcome back! Today we are talking about Aripiprazole, brand name Abilify.
Welcome back and Happy New Year! Today, we are kicking it off with a brief episode on Quetiapine (Seroquel).
Welcome back! Today, we have a short-episode on a unique second generation anti-psychotic, Asenapine (Saphris, Secuado).
Welcome back, on today's episode we will briefly go over the extrapyramidal symptoms associated with anti-psychotics.
Dr. Larry Wang will be hosting todays episode with a very special guest. . . another Dr. Larry Wang? . . . Bipolar depression being treated with an antidepressant? Welcome to the multiverse.
Welcome back to our antipsychotic series. Today, we will be discussing Olanzapine, brand-name, Zyprexa.
Welcome to another special guest episode. In this episode, we are joined by Dr. Christine Yu Moutier, M.D., the acting Chief Medical Officer of the American Foundation for Suicide Prevention. We’ll be discussing important topics around suicide prevention and much more. AFSP: https://afsp.org/ Suicide Prevention Handbook: https://www.cambridge.org/core/books/suicide-prevention/8BE216EF6EF05ABAF83B5C0D7FC9B969...
Join us as we take a break from some psychopharmacology. Today, we will be talking about CBT-I, one of the first-line therapy interventions for insomnia.
